Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 2/20 | 0.39 |
| ▸ | MMP2 | P08253 | 2/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
| ▸ | LIMK2 | P53671 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
| ▸ | MMP1 | P03956 | 1/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.35 |
| ▸ | MMP7 | P09237 | 1/20 | 0.35 |
| ▸ | MMP13 | P45452 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5770237 | 0.91 | MMP2 (0.41) | MMP2MMP9LIMK2HTTKEAP1 | |
| SCHEMBL5771248 | 0.89 | MMP9 (0.40) | MMP2MMP9HTTKEAP1MMP1 | |
| SCHEMBL6199952 | 0.88 | PSEN1 (0.43) | OPRK1MMP2MMP9LIMK2OPRM1 | |
| SCHEMBL1602483 | 0.87 | MMP2 (0.44) | OPRK1MMP2MMP9LIMK2HTT | |
| SCHEMBL5771490 | 0.82 | — | — | |
| SCHEMBL5771493 | 0.82 | — | — | |
| SCHEMBL1602322 | 0.80 | ABCB1 (0.51) | — | |
| SCHEMBL1600931 | 0.80 | ABCB1 (0.51) | — | |
| SCHEMBL6617050 | 0.77 | MMP2 (0.43) | MMP2MMP9HTTMMP1MMP3 | |
| SCHEMBL1601963 | 0.77 | MMP2 (0.48) | MMP2MMP9LIMK2HTTKEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1637518-A2 | Inhibitors of aspartyl protease | Vertex Pharmaceuticals Incorporated (US) | 2006-03-22 | — | — | EP | disclosed |